EMD Serono / Merck KGaA: Clinical Trials & Research Profile
Biopharma Industry (Darmstadt, DE / Rockland, MA) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Darmstadt, DE / Rockland, MA) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 13 active (6 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 46 (26 with California sites) |
| Completed vs Early-Stopped Studies | 18 completed / 15 stopped (32.6% stop rate) |
| Median Closed Enrollment | 140 participants |
| FDA Drugs@FDA Original Approvals | 19 all-time (2 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 83.0% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk